Verus Capital Partners, Llc
Source: SEC Form 13F · as of Mar 2026Verus Capital Partners, Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $20.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$20.1M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 53,144 | $11.6M |
| JNJJOHNSON & JOHNSON | 7,335 | $1.8M |
| BMYBRISTOL MYERS SQUIBB CO | 16,842 | $1.0M |
| MRKMerck & Co., Inc. | 8,378 | $1.0M |
| LLYELI LILLY & Co | 956 | $879K |
| PMPhilip Morris International Inc | 3,748 | $620K |
| SRRKScholar Rock Holding Corp | 10,490 | $516K |
| PFEPFIZER INC | 16,949 | $476K |
| ABTABBOTT LABORATORIES | 4,260 | $437K |
| AMGNAMGEN INC | 1,161 | $409K |
| GILDGILEAD SCIENCES, INC. | 2,882 | $402K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,392 | $377K |
| MCKMcKesson Corporation | 292 | $253K |
| AQSTAquestive Therapeutics, Inc. | 51,625 | $214K |
| EBSEmergent BioSolutions Inc. | 10,000 | $83K |
| ABUSArbutus Biopharma Corp | 15,250 | $69K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.